The CEO of OpenAI and creator of ChatGPT, Sam Altman, is not just focused on business related to artificial intelligence. This is because now, he is directing his efforts to try to reprogram the human body. In fact, this initiative has already been in existence for three years.
It was in 2021 that Altman launched a venture parallel to the presidency of OpenAI. Firstly, he invested US$180 million in the startup “Retro Biosciences“. So much so that it aims to add 10 healthy years to the end of lives – a vision that aligns with the billionaire’s futuristic perspective.
Later, to realize this vision, Altman teamed up with Joe Betts-LaCroix, a scientist, biophysicist and computer genius trained at Harvard, MIT and Caltech, known for developing the world’s smallest personal computer. Betts-LaCroix is a longtime advocate of rigorous science and “deep biology” for longevity through his nonprofit organization, the Health Extension Foundation.
Creator of ChatGPT and owner of Retro Biosciences
Retro Biosciences is characterized by having a typical Silicon Valley spirit. Its headquarters is a warehouse-like office, and its laboratories consist of a set of shipping containers. The startup continues to invest in three anti-aging techniques: autophagy, cell reprogramming and plasma therapy.
The first technique focuses on creating a cell-recycling pill, with research aimed at providing a “quick” solution to aging. Cellular reprogramming, in turn, seeks to rejuvenate old cells using four “Yamanaka” factors. And plasma therapy, which many consider the most promising, has already shown improvements in tests with mice and may have potential for application in humans.
Jeff Bezos also wants to invest in the topic
Altman isn’t the only tech mogul investing in this field. Jeff Bezos also injected hundreds of millions of dollars into Altos Labs, a biotechnology company in San Diego, considered the best-funded longevity laboratory on the market. It is still too early to say whether Altman’s approach will guarantee the development of a life-extending product, but if scientists succeed, the impacts on business and health could be significant.
Source: Atrevida
Earl Johnson is a music writer at Gossipify, known for his in-depth analysis and unique perspective on the industry. A graduate of USC with a degree in Music, he brings years of experience and passion to his writing. He covers the latest releases and trends, always on the lookout for the next big thing in music.
